ENTRY       D04813            Mixture   Drug
NAME        Lidocaine hydrochloride and epinephrine bitartrate;
            Lidocaine hydrochloride and adrenaline bitartrate;
            Ora (TN);
            Lidosite (TN)
PRODUCT     LIDOCAINE HCI AND EPINEPHRINE (HF Acquisition Co LLC)
            LIDOCAINE HCI AND EPINEPHRINE (HF Acquisition Co LLC)
            LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE (HF Acquisition Co LLC)
            XYLOCAINE (Fresenius Kabi USA)
            XYLOCAINE (Fresenius Kabi USA)
            XYLOCAINE (General Injectables & Vaccines)
            XYLOCAINE (General Injectables & Vaccines)
            XYLOCAINE (General Injectables & Vaccines)
            XYLOCAINE (General Injectables & Vaccines)
            XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) (HF Acquisition Co LLC)
            XYLOCAINE-MPF WITH EPI (HF Acquisition Co LLC)
  GENERIC   LIDOCAINE (Benco Dental)
            LIDOCAINE (Benco Dental)
            LIDOCAINE (Darby Dental Supply)
            LIDOCAINE (Darby Dental Supply)
            LIDOCAINE (Henry Schein)
            LIDOCAINE (Henry Schein)
            LIDOCAINE (NDC)
            LIDOCAINE (Patterson Dental)
            LIDOCAINE (Patterson Dental)
            LIDOCAINE (Safco Dental Supply)
            LIDOCAINE (Septodont)
            LIDOCAINE (Septodont)
            LIDOCAINE (The Atlanta Dental Supply Company DBA Advanced Dental Products)
            LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE (IQ Dental)
            LIGNOSPAN FORTE (Septodont)
            LIGNOSPAN STANDARD (Septodont)
            XYLOCAINE (Dentsply Pharmaceutical)
COMPONENT   (Lidocaine hydrochloride [DR:D02086] | Lidocaine hydrochloride monohydrate [DR:D08127]), Epinephrine bitartrate [DR:D02149]
CLASS       Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2710
            Product: D04813<JP/US>
EFFICACY    Anesthetic (topical, dental)
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       USP drug classification [BR:br08302]
             Anesthetics
              Local Anesthetics
               Lidocaine/ Epinephrine
                D04813  Lidocaine hydrochloride and epinephrine bitartrate
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              27  Dental preparations
               271  Local anesthetics
                2710  Local anesthetics
                 D04813  Lidocaine hydrochloride and epinephrine bitartrate
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D04813  Lidocaine hydrochloride and epinephrine bitartrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D04813  Lidocaine hydrochloride and epinephrine bitartrate
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04813
DBLINKS     PubChem: 17398182
///
